Topical Dermatologic Corticosteroids: In Vivo Bioequivalence; Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2022-D-2170
Documents
3
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Other· Jul 14, 2026Topical Dermatologic Corticosteroids: In Vivo Bioequivalence; Guidance for Industry; Final Guidance→No comment period
- Other· Oct 24, 2022Closed on Dec 24, 2022